Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET/CT: SUVmax versus total lung glycolysis.

Schimmelpennink MC, Vorselaars ADM, Veltkamp M, Keijsers RGM.

EJNMMI Res. 2019 Jun 13;9(1):54. doi: 10.1186/s13550-019-0505-x.

2.

Efficacy and safety of infliximab biosimilar Inflectra® in severe sarcoidosis.

Schimmelpennink MC, Vorselaars ADM, van Beek FT, Crommelin HA, Deneer VHM, Keijsers RGM, Veltkamp M.

Respir Med. 2018 May;138S:S7-S13. doi: 10.1016/j.rmed.2018.02.009. Epub 2018 Feb 19.

PMID:
29496351
3.

Cardiac sarcoidosis: challenges in clinical practice.

Bakker AL, Grutters JC, Keijsers RG, Post MC.

Curr Opin Pulm Med. 2017 Sep;23(5):468-475. doi: 10.1097/MCP.0000000000000410. Review.

PMID:
28661904
4.

⁹⁹mTc-anti-TNF-α antibody for the imaging of disease activity in pulmonary sarcoidosis.

Vis R, Malviya G, Signore A, Grutters JC, Meek B, van de Garde EM, Keijsers RG.

Eur Respir J. 2016 Apr;47(4):1198-207. doi: 10.1183/13993003.01352-2015. Epub 2016 Jan 21.

5.

Chest Imaging.

Keijsers RG, Veltkamp M, Grutters JC.

Clin Chest Med. 2015 Dec;36(4):603-19. doi: 10.1016/j.ccm.2015.08.004. Review.

PMID:
26593136
6.

Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis.

Vorselaars AD, Crommelin HA, Deneer VH, Meek B, Claessen AM, Keijsers RG, van Moorsel CH, Grutters JC.

Eur Respir J. 2015 Jul;46(1):175-85. doi: 10.1183/09031936.00227014. Epub 2015 Apr 30.

7.

Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy?

van Hoeij FB, Keijsers RG, Loffeld BC, Dun G, Stadhouders PH, Weusten BL.

Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):66-71. doi: 10.1007/s00259-014-2887-3. Epub 2014 Aug 20.

PMID:
25139518
8.

FDG PET for gauging of sarcoid disease activity.

Adams H, Keijsers RG, Korenromp IH, Grutters JC.

Semin Respir Crit Care Med. 2014 Jun;35(3):352-61. doi: 10.1055/s-0034-1376866. Epub 2014 Jul 9.

PMID:
25007087
9.

Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis.

Vorselaars AD, Verwoerd A, van Moorsel CH, Keijsers RG, Rijkers GT, Grutters JC.

Eur Respir J. 2014 Feb;43(2):602-9. doi: 10.1183/09031936.00055213. Epub 2013 Aug 29.

10.

Earlobe sarcoidosis.

Vorselaars AD, Keijsers RG, Grutters JC.

Sarcoidosis Vasc Diffuse Lung Dis. 2012 Mar;29(1):55-7.

PMID:
23311125
11.

Imaging the inflammatory activity of sarcoidosis.

Keijsers RG, van den Heuvel DA, Grutters JC.

Eur Respir J. 2013 Mar;41(3):743-51. doi: 10.1183/09031936.00088612. Epub 2012 Sep 27. Review.

12.

18F-FDG PET as a predictor of pulmonary function in sarcoidosis.

Keijsers RG, Verzijlbergen EJ, van den Bosch JM, Zanen P, van de Garde EM, Oyen WJ, Grutters JC.

Sarcoidosis Vasc Diffuse Lung Dis. 2011 Oct;28(2):123-9.

PMID:
22117503
13.

Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET.

Keijsers RG, Grutters JC, Thomeer M, Du Bois RM, Van Buul MM, Lavalaye J, Van Den Bosch JM, Verzijlbergen FJ.

Q J Nucl Med Mol Imaging. 2011 Feb;55(1):66-71. Epub 2011 Jan 18.

PMID:
21242947
14.

(18)F-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis.

Keijsers RG, Grutters JC, van Velzen-Blad H, van den Bosch JM, Oyen WJ, Verzijlbergen FJ.

Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1181-8. doi: 10.1007/s00259-009-1376-6. Epub 2010 Feb 16.

PMID:
20157709
15.

Invasive inflammatory myofibroblastic tumor of the lung.

van den Heuvel DA, Keijsers RG, van Es HW, Bootsma GP, de Bruin PC, Schramel FM, van Heesewijk JP.

J Thorac Oncol. 2009 Jul;4(7):923-6. doi: 10.1097/JTO.0b013e3181a76e28.

16.

18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab.

Keijsers RG, Verzijlbergen JF, van Diepen DM, van den Bosch JM, Grutters JC.

Sarcoidosis Vasc Diffuse Lung Dis. 2008 Dec;25(2):143-9.

PMID:
19382534
17.

18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis.

Keijsers RG, Verzijlbergen FJ, Oyen WJ, van den Bosch JM, Ruven HJ, van Velzen-Blad H, Grutters JC.

Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1131-7. doi: 10.1007/s00259-009-1097-x. Epub 2009 Mar 4.

PMID:
19259660
18.

Recurrent pneumonia due to an appendiceal mucinous cystadenocarcinoma: a rare presentation of a rare malignancy.

Gerritsen KG, Slee PH, Bollen TL, van Hecke W, Seldenrijk CA, Keijsers RG, Duurkens VA.

Clin Med Oncol. 2009 Mar 2;3:9-12.

19.

Cardiac sarcoidosis: a challenge to measure disease activity.

Keijsers RG, Verzijlbergen FJ, Rensing BJ, Grutters JC.

J Nucl Cardiol. 2008 Jul-Aug;15(4):595-8. doi: 10.1016/j.nuclcard.2008.02.033. Epub 2008 Apr 8. No abstract available.

PMID:
18674727
20.

[Three previously healthy persons with a stress fracture].

Tiel-van BM, Lavalaye J, Keijsers RG, Verzijlbergen JF.

Ned Tijdschr Geneeskd. 2007 May 19;151(20):1154-5; author reply 1155. Dutch. No abstract available.

PMID:
17557673

Supplemental Content

Loading ...
Support Center